Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      Homedrug manufacturers

      drug manufacturers

      Sanofi/Regeneron Dupixent Exhibits Effectiveness for up to 2 Years, in Children With Asthma
      Investing News

      Sanofi/Regeneron Dupixent Exhibits Effectiveness for up to 2 Years, in Children With Asthma

      September 6, 2022
      Kimberly-Clark Is Working to Reduce Costs Amid Soaring Prices
      Trading Tips

      Kimberly-Clark Is Working to Reduce Costs Amid Soaring Prices

      September 6, 2022
      FDA Approves Vertex’s CF Drug for Toddlers
      Investing News

      FDA Approves Vertex’s CF Drug for Toddlers

      September 5, 2022
      Taiwan Approves Moderna’s COVID-19 Vaccine That Targets Omicron
      Investing News

      Taiwan Approves Moderna’s COVID-19 Vaccine That Targets Omicron

      September 2, 2022
      Novartis’ Drug for Chronic Myeloid Leukemia Receives EC Approval
      Investing News

      Novartis’ Drug for Chronic Myeloid Leukemia Receives EC Approval

      August 30, 2022
      Bristol-Myers Slumps 5% Largest Drop In 2 Years Following Mid-Stage Data for Blood Thinner
      Investing News

      Bristol-Myers Slumps 5% Largest Drop In 2 Years Following Mid-Stage Data for Blood Thinner

      August 29, 2022
      Omicron-Based Booster: Pfizer and BioNTech Seeking EU Approval
      Investing News

      Omicron-Based Booster: Pfizer and BioNTech Seeking EU Approval

      August 29, 2022
      Should Pfizer Shareholders be Concerned About Declining Demand for COVID-19 Vaccine?
      Trading Tips

      Should Pfizer Shareholders be Concerned About Declining Demand for COVID-19 Vaccine?

      August 26, 2022
      Battle for mRNA technology, Moderna sues Pfizer and BioNTech for patent infringement
      Investing News

      Battle for mRNA technology, Moderna sues Pfizer and BioNTech for patent infringement

      August 26, 2022
      Japan Approves AstraZeneca’s Request to Widen Use of 3 Drugs
      Investing News

      Japan Approves AstraZeneca’s Request to Widen Use of 3 Drugs

      August 25, 2022
      « 1 2 3 4 »

       

      LATEST NEWS

      • Investing News Beta Technologies Q3 IPO Insights
      • Investing News Salesforce Reports Robust Q3 2026 Earnings
      • Investing News Salesforce’s Stock Boost Amid Raised Guidance
      • Investing News Macy’s Q3 2025 Earnings Overview
      • Investing News Okta’s Strong Q3 2026 Earnings Boost Shares

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2025